Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
Prediction market platform Kalshi is expanding into biotech, launching contracts Wednesday night that let traders bet on clinical trial outcomes and drug approvals from companies including Sanofi (NASDAQ: SNY ) and Gilead Sciences Inc (NASDAQ: GILD ). The 13 new contracts were launched in partnership with AppliedXL, an